VSee Health 2025 10-K: Revenue Up 40% to $14.6M, Still Reports $(0.73) Loss Per Share
Summary
VSee Health reported its 2025 annual financial results from its 10-K filing, revealing a 40% year-over-year revenue increase to $14.62 million, primarily driven by the iDoc acquisition and higher telehealth volume. Despite this significant top-line growth, the company posted a basic and diluted loss per share of $(0.73) and a net loss of $(14.74) million. While the net loss improved materially from the prior year due to the absence of a goodwill impairment, the company continues to operate at a substantial loss. For a micro-cap company, sustained losses, even with revenue growth, raise concerns about long-term viability and cash burn. Traders will be watching for signs of profitability or a clear path to it, as well as continued revenue growth momentum.
At the time of this announcement, VSEE was trading at $0.25 on NASDAQ in the Technology sector, with a market capitalization of approximately $10.8M. The 52-week trading range was $0.19 to $2.52. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.